52 related articles for article (PubMed ID: 1509413)
1. Characterization of three alboaggregins purified from Trimeresurus albolabris venom.
Peng M; Lu W; Kirby EP
Thromb Haemost; 1992 Jun; 67(6):702-7. PubMed ID: 1509413
[TBL] [Abstract][Full Text] [Related]
2. Binding of a novel 50-kilodalton alboaggregin from Trimeresurus albolabris and related viper venom proteins to the platelet membrane glycoprotein Ib-IX-V complex. Effect on platelet aggregation and glycoprotein Ib-mediated platelet activation.
Andrews RK; Kroll MH; Ward CM; Rose JW; Scarborough RM; Smith AI; López JA; Berndt MC
Biochemistry; 1996 Sep; 35(38):12629-39. PubMed ID: 8823201
[TBL] [Abstract][Full Text] [Related]
3. Alboaggregin-B and botrocetin, two snake venom proteins with highly homologous amino acid sequences but totally distinct functions on von Willebrand factor binding to platelets.
Yoshida E; Fujimura Y; Miura S; Sugimoto M; Fukui H; Narita N; Usami Y; Suzuki M; Titani K
Biochem Biophys Res Commun; 1993 Mar; 191(3):1386-92. PubMed ID: 8466514
[TBL] [Abstract][Full Text] [Related]
4. Alboaggregin-B: a new platelet agonist that binds to platelet membrane glycoprotein Ib.
Peng M; Lu W; Kirby EP
Biochemistry; 1991 Dec; 30(49):11529-36. PubMed ID: 1747371
[TBL] [Abstract][Full Text] [Related]
5. Alboaggregins A and B. Structure and interaction with human platelets.
Kowalska MA; Tan L; Holt JC; Peng M; Karczewski J; Calvete JJ; Niewiarowski S
Thromb Haemost; 1998 Mar; 79(3):609-13. PubMed ID: 9531050
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of jararaca GPIb-BP, a snake venom antagonist specific to platelet glycoprotein Ib.
Fujimura Y; Ikeda Y; Miura S; Yoshida E; Shima H; Nishida S; Suzuki M; Titani K; Taniuchi Y; Kawasaki T
Thromb Haemost; 1995 Aug; 74(2):743-50. PubMed ID: 8585016
[TBL] [Abstract][Full Text] [Related]
7. Echicetin: a snake venom protein that inhibits binding of von Willebrand factor and alboaggregins to platelet glycoprotein Ib.
Peng M; Lu W; Beviglia L; Niewiarowski S; Kirby EP
Blood; 1993 May; 81(9):2321-8. PubMed ID: 8481512
[TBL] [Abstract][Full Text] [Related]
8. Bilinexin, a snake C-type lectin from Agkistrodon bilineatus venom agglutinates platelets via GPIb and alpha2beta1.
Du XY; Navdaev A; Clemetson JM; Magnenat E; Wells TN; Clemetson KJ
Thromb Haemost; 2001 Nov; 86(5):1277-83. PubMed ID: 11816718
[TBL] [Abstract][Full Text] [Related]
9. A novel tetrameric venom protein, agglucetin from Agkistrodon acutus, acts as a glycoprotein Ib agonist.
Wang WJ; Huang TF
Thromb Haemost; 2001 Oct; 86(4):1077-86. PubMed ID: 11686327
[TBL] [Abstract][Full Text] [Related]
10. Tokaracetin, a new platelet antagonist that binds to platelet glycoprotein ib and inhibits von Willebrand factor-dependent shear-induced platelet aggregation.
Kawasaki T; Taniuchi Y; Hisamichi N; Fujimura Y; Suzuki M; Titani K; Sakai Y; Kaku S; Satoh N; Takenaka T
Biochem J; 1995 Jun; 308 ( Pt 3)(Pt 3):947-53. PubMed ID: 8948455
[TBL] [Abstract][Full Text] [Related]
11. Alboluxin, a snake C-type lectin from Trimeresurus albolabris venom is a potent platelet agonist acting via GPIb and GPVI.
Du Xiao-Yan ; Magnenat E; Wells TN; Clemetson KJ
Thromb Haemost; 2002 Apr; 87(4):692-8. PubMed ID: 12008953
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning and sequence analysis of alboaggregin B.
Arpijuntarangkoon J; Rojnuckarin P; Muanpasitporn C; Kaeothip S; Sangvanich P; Intragumtornchai T
Platelets; 2007 Jun; 18(4):266-72. PubMed ID: 17538847
[TBL] [Abstract][Full Text] [Related]
13. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib.
Girma JP; Takahashi Y; Yoshioka A; Diaz J; Meyer D
Thromb Haemost; 1990 Oct; 64(2):326-32. PubMed ID: 1702906
[TBL] [Abstract][Full Text] [Related]
14. The cDNA cloning and molecular characterization of a snake venom platelet glycoprotein Ib-binding protein, mamushigin, from Agkistrodon halys blomhoffii venom.
Sakurai Y; Fujimura Y; Kokubo T; Imamura K; Kawasaki T; Handa M; Suzuki M; Matsui T; Titani K; Yoshioka A
Thromb Haemost; 1998 Jun; 79(6):1199-207. PubMed ID: 9657448
[TBL] [Abstract][Full Text] [Related]
15. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation.
Grainick HR; Williams SB; Coller BS
J Clin Invest; 1985 Jan; 75(1):19-25. PubMed ID: 2981249
[TBL] [Abstract][Full Text] [Related]
16. How does agkicetin-C bind on platelet glycoprotein Ibalpha and achieve its platelet effects?
Xu G; Ulrichts H; Vauterin S; De Meyer SF; Deckmyn H; Teng M; Niu L
Toxicon; 2005 Apr; 45(5):561-70. PubMed ID: 15777951
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of von Willebrand factor-induced platelet agglutination by ADP does not result from reduced binding of total von Willebrand factor or its larger multimers.
Zucker MB; Puszkin EG; Sussman II; Mauss EA
J Lab Clin Med; 1990 Sep; 116(3):305-14. PubMed ID: 2401846
[TBL] [Abstract][Full Text] [Related]
18. Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand disease.
Tout H; Obert B; Houllier A; Fressinaud E; Rothschild C; Meyer D; Girma JP
Thromb Haemost; 2000 Feb; 83(2):274-81. PubMed ID: 10739386
[TBL] [Abstract][Full Text] [Related]
19. Flavocetin-A and -B, two high molecular mass glycoprotein Ib binding proteins with high affinity purified from Trimeresurus flavoviridis venom, inhibit platelet aggregation at high shear stress.
Taniuchi Y; Kawasaki T; Fujimura Y; Suzuki M; Titani K; Sakai Y; Kaku S; Hisamichi N; Satoh N; Takenaka T
Biochim Biophys Acta; 1995 Jun; 1244(2-3):331-8. PubMed ID: 7599152
[TBL] [Abstract][Full Text] [Related]
20. Inhibition assay for the binding of biotinylated von Willebrand factor to platelet-bound microtiter wells in the presence of ristocetin or botrocetin.
Miura S; Nishida S; Makita K; Sakurai Y; Shimoyama T; Sugimoto M; Yoshioka A; Ishii K; Kito M; Kobayashi T; Fujimura Y
Anal Biochem; 1996 May; 236(2):215-20. PubMed ID: 8660497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
